Back
Rhythm Pharmaceuticals Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
50
RYTM
Rhythm Pharmaceuticals
Last Price:
$58.93
Seasonality Move:
54.9%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bearish and RYTM is experiencing slight buying pressure.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.08 | Sell |
| 20-day SMA: | 62.15 | Sell |
| 50-day SMA: | 56.78 | Buy |
| 200-day SMA: | 54.27 | Buy |
| 8-day EMA: | 61.17 | Sell |
| 20-day EMA: | 61 | Sell |
| 50-day EMA: | 58.76 | Buy |
| 200-day EMA: | 53.68 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.04 | Buy |
| Relative Strength Index (14 RSI): | 46.88 | Sell |
| Chaikin Money Flow: | 27337 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.61 - 64.05) | Sell |
| Bollinger Bands (100): | (52.9 - 60.74) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 58.97 while RYTM 8-day simple moving average is 62.08, which is a Sell signal.
-
The stock price of RYTM is 58.97 while Rhythm Pharmaceuticals 20-day SMA is 62.15, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day simple moving average is 56.78 while RYTM share price is 58.97, making it a Buy technically.
-
RYTM stock price is 58.97 and Rhythm Pharmaceuticals 200-day simple moving average is 54.27, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Sell
50
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a SellThe current Rhythm Pharmaceuticals [RYTM] share price is $58.97. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.8B
Price in USD:
58.97
Share Volume:
562K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
68.58
52-Week Low:
35.17
Sell
50
Rhythm Pharmaceuticals (RYTM)
is a Sell
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?The Rhythm Pharmaceuticals stock price is 58.97 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 58.97 while RYTM 8-day exponential moving average is 61.17, which is a Sell signal.
-
The stock price of RYTM is 58.97 while Rhythm Pharmaceuticals 20-day EMA is 61.00, which makes it a Sell.
-
Rhythm Pharmaceuticals 50-day exponential moving average is 58.76 while RYTM share price is 58.97, making it a Buy technically.
-
RYTM stock price is 58.97 and Rhythm Pharmaceuticals 200-day simple moving average is 53.68, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is 1.04, suggesting Rhythm Pharmaceuticals is a Buy
-
Rhythm Pharmaceuticals Relative Strength Index (RSI) is 46.88, which suggest Rhythm Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals is (58.61 - 64.05), which suggest Rhythm Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals is (52.9 - 60.74), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.